Latest return on equity
ARS Pharmaceuticals Return on equity
Direct answer
ARS Pharmaceuticals's return on equity is -210.35%.
The verified market snapshot reports -210.35%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free ARS Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -210.35%
Explore related company data
View ARS Pharmaceuticals's market capitalizationView ARS Pharmaceuticals's price-to-book ratioView ARS Pharmaceuticals's dividend yieldView ARS Pharmaceuticals's 52-week price rangeView ARS Pharmaceuticals's revenue growthView ARS Pharmaceuticals's profit marginView ARS Pharmaceuticals's debt-to-equity ratioView all ARS Pharmaceuticals key metricsReturn to ARS Pharmaceuticals profile